(19)
(11) EP 1 217 101 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.02.2006 Bulletin 2006/05

(45) Mention of the grant of the patent:
23.11.2005 Bulletin 2005/47

(21) Application number: 01125379.6

(22) Date of filing: 26.04.1995
(51) International Patent Classification (IPC): 
C25D 13/00(1974.07)
A61F 2/06(1985.01)
A61L 31/00(1985.01)
 C25D 9/00(1974.07)
A61L 27/00(1985.01)

(54)

Stent with collagen

Stent mit Kollagen

Extenseur au collagène

(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 29.04.1994 US 235300
06.12.1994 US 350223

(43) Date of publication of application:
26.06.2002 Bulletin 2002/26

(62) Application number of the earlier application in accordance with Art. 76 EPC:
95917692.6 / 0754017

(73) Proprietor: Boston Scientific Scimed, Inc.
Maple Grove, MN 55311 (US)

(72) Inventors:
  • Buirge, Andrew W.
    Minneapolis, MN 55406 (US)
  • Buscemi, Paul J.
    Long Lake, MN 55356 (US)
  • Burmeister, Paul H.
    Maple Grove, MN 55311 (US)

(74) Representative: Maiwald Patentanwalts GmbH 
Elisenhof, Elisenstrasse 3
80335 München
80335 München (DE)


(56) References cited: : 
EP-A- 0 362 444
DE-C- 4 303 575
US-A- 3 892 648
US-A- 5 195 984
 DE-A- 4 040 850
FR-A- 2 606 403
US-A- 4 503 569
US-A- 5 205 921
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).